These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1150539)

  • 21. A new antibiotic K-82 A and minor components, produced by Streptomyces lavendulae, strain No. K-82.
    Shibata M; Uyeda M; Kido Y; Toya N; Nakashima R; Terazumi R
    J Antibiot (Tokyo); 1980 Nov; 33(11):1231-5. PubMed ID: 7251468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioconversion of leucomycins and its regulation by butyrate in a producing strain.
    Omura S; Miyazawa J; Takeshima H; Kitao C; Atsumi K
    J Antibiot (Tokyo); 1976 Oct; 29(10):1131-3. PubMed ID: 994332
    [No Abstract]   [Full Text] [Related]  

  • 23. [Isolation, purification and separation of the polyether antibiotic complex IM-15 from a strain of Streptomyces sp. 15].
    Ivanova V; Gesheva V; Gesheva R; Liubenova V; Panaĭotov P
    Acta Microbiol Bulg; 1988; 22():61-7. PubMed ID: 3150248
    [No Abstract]   [Full Text] [Related]  

  • 24. The microbial transformation of tylosin by the spiramycin-producing strain, Streptomyces ambofaciens KA-1028.
    Omura S; Kitao C; Sadakane N
    J Antibiot (Tokyo); 1980 Aug; 33(8):911-2. PubMed ID: 7429995
    [No Abstract]   [Full Text] [Related]  

  • 25. Biological glycosidation of macrolide aglycones. I. Isolation and characterization of 5-O-mycaminosyl narbonolide and 9-dihydro-5-O-mycaminosyl narbonolide.
    Maezawa I; Kinumaki A; Suzuki M
    J Antibiot (Tokyo); 1976 Nov; 29(11):1203-8. PubMed ID: 993106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maridomycin, a new macrolide antibiotic. XI. The structures of maridomycin components.
    Muroi M; Izawa M; Kishi T
    Chem Pharm Bull (Tokyo); 1976 Mar; 24(3):463-78. PubMed ID: 1021252
    [No Abstract]   [Full Text] [Related]  

  • 27. Paulomycins A and B. Isolation and characterization.
    Argoudelis AD; Brinkley TA; Brodasky TF; Buege JA; Meyer HF; Mizsak SA
    J Antibiot (Tokyo); 1982 Mar; 35(3):285-94. PubMed ID: 7076577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Metabolic products of microorganisms. 3 lipomycins. I. Isolation, characterization and first studies of the structure and the mechanism of action].
    Kunze B; Schabacher K; Zähner H; Zeeck A
    Arch Mikrobiol; 1972; 86(2):147-74. PubMed ID: 4628181
    [No Abstract]   [Full Text] [Related]  

  • 29. Isolation and characterization of ericamycin, a new antibiotic.
    Shimura M; Kondo S; Nishio T; Akita E; Satoh K; Hara T
    J Antibiot (Tokyo); 1966 Mar; 19(2):51-5. PubMed ID: 5952891
    [No Abstract]   [Full Text] [Related]  

  • 30. Isolation, purification, and characterization of anticapsin.
    Shah R; Neuss N; Gorman M; Boeck LD
    Jpn J Antibiot; 1970 Dec; 23(6):613-7. PubMed ID: 4923584
    [No Abstract]   [Full Text] [Related]  

  • 31. Isolation and characterization of 23-O-mycinosyl-20-dihydro-rosamicin: a new rosamicin analogue derived from engineered Micromonospora rosaria.
    Anzai Y; Sakai A; Li W; Iizaka Y; Koike K; Kinoshita K; Kato F
    J Antibiot (Tokyo); 2010 Jun; 63(6):325-8. PubMed ID: 20414322
    [No Abstract]   [Full Text] [Related]  

  • 32. Microbial conversion of antibiotics. IV. Reduction of maridomycin.
    Nakahama K; Igarasi S
    J Antibiot (Tokyo); 1974 Aug; 27(8):605-9. PubMed ID: 4436146
    [No Abstract]   [Full Text] [Related]  

  • 33. Microbial transformation of leucomycin A5.
    Singh K; Rakhit S
    J Antibiot (Tokyo); 1979 Jan; 32(1):78-80. PubMed ID: 761994
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on new antibiotic lividomycins. II. Isolation and characterization of lividomycins A, B and other aminoglycosidic antibiotics produced by Streptomyces lividus.
    Mori T; Ichiyanagi T; Kondŏ H; Tokunaga K; Oda T
    J Antibiot (Tokyo); 1971 Jun; 24(6):339-46. PubMed ID: 5091209
    [No Abstract]   [Full Text] [Related]  

  • 35. New antibiotic U-64846: fermentation, isolation and characterization.
    Dolak LA; Castle TM; Hannon BR; Reusser F
    J Antibiot (Tokyo); 1984 Feb; 37(2):96-102. PubMed ID: 6706857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on antibiotic SF-837, a new antibiotic. I. The producing microorganism and isolation and characterization of the antibiotic.
    Tsuruoka T; Shomura T; Ezaki N; Watanabe H; Akita E
    J Antibiot (Tokyo); 1971 Jul; 24(7):452-9. PubMed ID: 5562042
    [No Abstract]   [Full Text] [Related]  

  • 37. NW-G01, a novel cyclic hexadepsipeptide antibiotic, produced by Streptomyces alboflavus 313: I. Taxonomy, fermentation, isolation, physicochemical properties and antibacterial activities.
    Guo Z; Shen L; Ji Z; Zhang J; Huang L; Wu W
    J Antibiot (Tokyo); 2009 Apr; 62(4):201-5. PubMed ID: 19265870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation, characterization and structures of PA-46101 A and B.
    Matsumoto M; Kawamura Y; Yoshimura Y; Terui Y; Nakai H; Yoshida T; Shoji J
    J Antibiot (Tokyo); 1990 Jul; 43(7):739-47. PubMed ID: 2387767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties of midecamycin, a new macrolide antibiotic.
    Salhi A; Vindel JA; Brunaud M; Berceaux G; Marin A; Wuatelet C
    G Ital Chemioter; 1977; 24(1-2):67-76. PubMed ID: 308022
    [No Abstract]   [Full Text] [Related]  

  • 40. [Metabolic products of microorganisms. 110. Biosynthesis of macrotetrolides tetrolides. 3. Isolation of free nonactinic acids and their function as precursors of the macrotetrolides].
    Stahl P; Pape H
    Arch Mikrobiol; 1972; 85(3):239-48. PubMed ID: 4627841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.